CGEM
Cullinan Therapeutics, Inc. Common Stock
stockNASDAQ
Market OpenNov 10, 2026 2:00:32 PM EST
11.15USD-4.945%(-0.58)404,732
Pre-marketNov 10, 2026 9:25:30 AM EST
11.62USD-0.938%(-0.11)
CGEM Financials
In Q3 FY 2026 (ended ), Cullinan Therapeutics, Inc. Common Stock (CGEM) reported operating cash flow of −$43.08M and assets of $322.56M (filed ).
Loading financial statements…